PGR
59
5
KMX
66
-2
FSLR
63
5
RL
75
3
SWKS
53
3
NKE
37
-3
FRT
46
3
MTCH
48
11
GT
56
-2
PNC
53
-2
BK
66
-2
VTR
43
-3
CVX
23
-2
EXPD
37
-2
XRAY
47
-2
LYB
25
-14
GOOG
81
-2
HUM
33
2
PRU
45
-2
NUE
39
-4
PGR
59
5
KMX
66
-2
FSLR
63
5
RL
75
3
SWKS
53
3
NKE
37
-3
FRT
46
3
MTCH
48
11
GT
56
-2
PNC
53
-2
BK
66
-2
VTR
43
-3
CVX
23
-2
EXPD
37
-2
XRAY
47
-2
LYB
25
-14
GOOG
81
-2
HUM
33
2
PRU
45
-2
NUE
39
-4
Financhill
Back

Goldman Sachs Acss Invmt Grd Corp Bd ETF Vs. NovoCure Industry Stock Comparison

Sell
41

GIGB
Goldman Sachs Acss Invmt Grd Corp Bd ETF

Last Price:
45.76
Seasonality Move:
-2.18%
Buy
75

NVCR
NovoCure

Last Price:
33.40
Seasonality Move:
-5.24%
Sell
41
Goldman Sachs Acss Invmt Grd Corp Bd ETF (GIGB) is a Sell

Is Goldman Sachs Acss Invmt Grd Corp Bd ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Acss Invmt Grd Corp Bd ETF [GIGB] share price is $45.78. The Score for GIGB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • GIGB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GIGB Stock Price Chart

What is Goldman Sachs Acss Invmt Grd Corp Bd ETF's stock price today?

  • The Goldman Sachs Acss Invmt Grd Corp Bd ETF share price today is $45.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GIGB is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $33.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

GIGB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 40.51 Sell
Chaikin Money Flow: -19138 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.71 - 46.29) Sell
Bollinger Bands (100): (45.88 - 47.02) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.78 Buy
Relative Strength Index (14 RSI): 75.34 Buy
Chaikin Money Flow: 1118573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.36 - 28.56) Buy
Bollinger Bands (100): (14.7 - 22.78) Buy

GIGB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.21 Sell
20-day SMA: 46.04 Sell
50-day SMA: 46.12 Sell
200-day SMA: 45.84 Sell
8-day EMA: 46.1 Sell
20-day EMA: 46.1 Sell
50-day EMA: 46.17 Sell
200-day EMA: 45.93 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.6 Buy
20-day SMA: 23.68 Buy
50-day SMA: 19.33 Buy
200-day SMA: 17.9 Buy
8-day EMA: 29.53 Buy
20-day EMA: 25.45 Buy
50-day EMA: 21.38 Buy
200-day EMA: 19.88 Buy

Goldman Sachs Acss Invmt Grd Corp Bd ETF Earnings Growth & GIGB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Goldman Sachs Acss Invmt Grd Corp Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):